HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Leucomycin A1

HCID 5282322
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1392-21-8
Standard SMILES
CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O
InChIKey
IEMDOFXTVAPVLX-YWQHLDGFSA-N
Molecular formula
C40H67NO14
Average molar mass
786 g/mol
Monoisotopic mass
785.45615581

Overview

Leucomycin A1 is a macrolide.

Names & identifiers

Preferred name
Leucomycin A1
IUPAC
[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate
English name
Turimycin H-5
Molecular formula
C40H67NO14
Molecular weight
785.96

Names & synonyms

Leucomycin A1Kitasamycin A1Turimycin H53-DeacetyljosamycinLeucomycin V 4-isovalerate3-O-DeacetyljosamycinLM-A19-Dihydroniddamycin16846-34-7Leucomycin V, 4B-(3-methylbutanoate)UNII-YX09Z4QW5YYX09Z4QW5Y
Show more names
Turimycin H-5Leucomycin V 4''-(3-methylbutanoate)KitasaMycin A1, TuriMycin H5, LeucoMycin V 4-isovalerate
[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoateLEUCOMYCIN A1 [MI]DTXSID501016463[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyl-tetrahydropyran-3-yl]oxy-4-hydroxy-2,4-dimethyl-tetrahydropyran-3-yl] 3-methylbutanoate((2S,3S,4R,6S)-6-((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyl-tetrahydropyran-3-yl)oxy-4-hydroxy-2,4-dimethyl-tetrahydropyran-3-yl) 3-methylbutanoate((2S,3S,4R,6S)-6-((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy-4-hydroxy-2,4-dimethyloxan-3-yl) 3-methylbutanoate(2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11Z,13Z,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy)-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoic acid(2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,10R,11Z,13Z,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoic acid

Properties

Computed structural properties

XLogP
2.4
Topological polar surface area
200 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
15
Rotatable bonds
12
Heavy atoms
55
Formal charge
0
Complexity
1,280

Experimental & physicochemical properties

DrugsPharmaceuticals -> Antibiotics
LogP2.18

Physicochemical properties

storage temp.
-20 °C · Store at -20°C
solubility
Soluble in DMSO
form
solid
FDA UNII
9 Z4QW5Y · YX09Z4QW5Y
Toxicity
50 intraperitoneal · LD50 intraperitoneal in mouse: 620mg/kg

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Toxicity
LD50 intraperitoneal in mouse: 620mg/kg

Chemistry & industry

Applications · 2 items

UsesLeucomycin A1 is a major and potent metabolite from the leucomycin complex.

UsesLeucomycin A1 is a major metabolite from the leucomycin complex, a family of closely related macrocyclic lactone antibiotics produced by Streptomyces kitasatoensis, discovered in 1953. Leucomycin complex (kitasamycin) is used as an animal health product for control of Gram positive bacteria, Gram negative cocci, leptospira and mycoplasma. Little is known about the activity of individual analogues within the complex as their limited availability has restricted investigation.

Additional notes

DefinitionChEBI: Leucomycin A1 is a macrolide.

Related reactions

1 records
New reaction record
HRID 1109840 reaction equation
HRID 1109840As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1392-21-8、16846-34-7
PubChem CID
5282322
DTXSID
DTXSID501016463
ChEMBL
CHEMBL2106399
ChEBI
CHEBI:34812
UNII
YX09Z4QW5Y